Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1997 3
1998 3
2001 1
2009 2
2010 2
2011 1
2012 3
2013 3
2014 8
2015 10
2016 16
2017 9
2018 17
2019 11
2020 14
2021 24
2022 27
2023 20
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
[Haemophilia].
Loomans JI, Lock J, Peters M, Leebeek FW, Cnossen MH, Fijnvandraat K. Loomans JI, et al. Among authors: cnossen mh. Ned Tijdschr Geneeskd. 2014;158:A7357. Ned Tijdschr Geneeskd. 2014. PMID: 25351381 Review. Dutch.
Defining patient value in haemophilia care.
van Balen EC, Gouw SC, Hazelzet JA, van der Bom JG, Cnossen MH. van Balen EC, et al. Among authors: cnossen mh. Haemophilia. 2018 Jul;24(4):516-518. doi: 10.1111/hae.13550. Haemophilia. 2018. PMID: 30141573 No abstract available.
Proteomic landscapes of inherited platelet disorders with different etiologies.
Kreft IC, Huisman EJ, Cnossen MH, van Alphen FPJ, van der Zwaan C, van Leeuwen K, van Spaendonk R, Porcelijn L, Veen CSB, van den Biggelaar M, de Haas M, Meijer AB, Hoogendijk AJ. Kreft IC, et al. Among authors: cnossen mh. J Thromb Haemost. 2023 Feb;21(2):359-372.e3. doi: 10.1016/j.jtha.2022.11.021. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36700500 Free article.
Diagnosis and management of haemophilia.
Fijnvandraat K, Cnossen MH, Leebeek FW, Peters M. Fijnvandraat K, et al. Among authors: cnossen mh. BMJ. 2012 May 2;344:e2707. doi: 10.1136/bmj.e2707. BMJ. 2012. PMID: 22551712 Free article. Review. No abstract available.
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study.
van Dijk MJ, Rab MAE, van Oirschot BA, Bos J, Derichs C, Rijneveld AW, Cnossen MH, Nur E, Biemond BJ, Bartels M, Jans JJM, van Solinge WW, Schutgens REG, van Wijk R, van Beers EJ. van Dijk MJ, et al. Among authors: cnossen mh. Am J Hematol. 2022 Jul;97(7):E226-E229. doi: 10.1002/ajh.26554. Epub 2022 Apr 16. Am J Hematol. 2022. PMID: 35384026 Free article. Clinical Trial. No abstract available.
Sickle cell disease: Clinical presentation and management of a global health challenge.
Houwing ME, de Pagter PJ, van Beers EJ, Biemond BJ, Rettenbacher E, Rijneveld AW, Schols EM, Philipsen JNJ, Tamminga RYJ, van Draat KF, Nur E, Cnossen MH; SCORE Consortium. Houwing ME, et al. Among authors: cnossen mh. Blood Rev. 2019 Sep;37:100580. doi: 10.1016/j.blre.2019.05.004. Epub 2019 May 20. Blood Rev. 2019. PMID: 31128863 Review.
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study.
van Dijk MJ, Rab MAE, van Oirschot BA, Bos J, Derichs C, Rijneveld AW, Cnossen MH, Nur E, Biemond BJ, Bartels M, Jans JJM, van Solinge WW, Schutgens REG, van Wijk R, van Beers EJ. van Dijk MJ, et al. Among authors: cnossen mh. Blood Adv. 2023 Dec 26;7(24):7539-7550. doi: 10.1182/bloodadvances.2023011477. Blood Adv. 2023. PMID: 37934880 Free PMC article. Clinical Trial.
159 results